Opinion: The Biden administration’s plan to use march-in rights to address drug prices would kill future world-changing innovations
The Bayh-Dole Act is widely credited with kickstarting a new era of American innovation involving the launch of 17,000 startup companies and some 495,000 inventions.
Yet despite this success, Bayh-Dole now finds itself vulnerable — and from a surprising source.
